SEC Form 4 · accession 0001144204-15-027984
NEOGENOMICS INC · NEO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert H. Horel
Officer — Vice President GM PathLogic
Period of report
May 4, 2015
Accepted (ET)
May 6, 2015 · 4:34 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001077183
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $4.78 | May 4, 2015 | A | 50,000 | A | May 4, 2016 | May 4, 2020 | Common Stock | 0 | 50,000 | D |
| Stock Option (Right to Buy)F1 | $1.45 | holding | — | — | — | May 20, 2012 | May 20, 2016 | Common Stock | 0 | 26,218 | D |
| Stock Option (Right to Buy)F2 | $1.69 | holding | — | — | — | Apr 12, 2012 | Apr 12, 2017 | Common Stock | 0 | 25,000 | D |
Explanation of responses
- F1On May 20, 2011 Mr. Horel was granted 50,000 stock options. These options vested ratably over the first four anniversaries of the grant date. On December 19, 2014 Mr. Horel exercised 23,782 options leaving a balance of 26,218
- F2On April 12, 2012 Mr. Horel was granted 25,000 stock options. 6,250 options vested immediately and 6,250 options vest on each of the next thre anniversaries from the grant date.
- F3On May 4, 2015 Mr. Horel was granted 50,000 stock options. These options vest ratably over the next 3 years on the anniversary date from date of grant.